A team of researchers at the Medical University of South Carolina has discovered that a commonly used drug, N-acetylcysteine ...
Clinical stage biopharmaceutical company Nacuity Pharmaceuticals announced that the US FDA has granted Fast Track designation for its NPI-001 (N-acetylcysteine amide) tablets, a proprietary ...
NPI-001 is a proprietary, GMP-grade formulation of N-acetylcysteine amide (NACA) tablets being developed to target oxidative stress associated with diseases such as retinitis pigmentosa.
As Los Angeles contends with the devastating effects of wildfires, medical experts provide tips to protect your lungs, skin and general well-being.